Gainers
- Guardant Health (NASDAQ:GH) stock rose 14.8% to $55.23 during Tuesday's after-market session. The market value of their outstanding shares is at $5.6 billion.
- ABVC BioPharma (NASDAQ:ABVC) stock moved upwards by 13.02% to $1.03. This security traded at a volume of 161.9K shares come close, making up 191.2% of its average volume over the last 100 days. The company's market cap stands at $33.2 million.
- PhaseBio Pharmaceuticals (NASDAQ:PHAS) shares rose 7.6% to $0.93. The company's market cap stands at $45.2 million.
- Unity Biotechnology (NASDAQ:UBX) shares moved upwards by 7.01% to $0.67. The market value of their outstanding shares is at $46.1 million.
- Synlogic (NASDAQ:SYBX) stock moved upwards by 6.36% to $1.17. The company's market cap stands at $82.1 million.
- Calyxt (NASDAQ:CLXT) stock increased by 5.63% to $0.26. The company's market cap stands at $11.0 million.
Losers
- Applied Genetic (NASDAQ:AGTC) stock declined by 31.2% to $0.58 during Tuesday's after-market session. Today's trading volume for this security ended up closing at 781.4K shares, which is 189.5 percent of its average volume over the last 100 days. The market value of their outstanding shares is at $29.5 million.
- Atara Biotherapeutics (NASDAQ:ATRA) shares declined by 30.61% to $6.01. Today's trading volume for this security ended up closing at 433.5K shares, which is 37.4 percent of its average volume over the last 100 days. The market value of their outstanding shares is at $561.3 million.
- Venus Concept (NASDAQ:VERO) shares decreased by 9.36% to $0.48. The company's market cap stands at $30.7 million.
- MyMD Pharmaceuticals (NASDAQ:MYMD) stock decreased by 6.6% to $4.67. The market value of their outstanding shares is at $177.7 million.
- ALX Oncology Holdings (NASDAQ:ALXO) stock declined by 6.32% to $9.5. The market value of their outstanding shares is at $386.4 million.
- Scholar Rock Holding (NASDAQ:SRRK) shares fell 6.25% to $7.5. The company's market cap stands at $387.2 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Market News and Data brought to you by Benzinga APIs
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
